Aadi Bioscience Presents Clinical Data from PRECISION 1 and AMPECT Trials at the Society of Gynecological Oncology (SGO) Annual Meeting on Women's Cancer

LOS ANGELES, March 26, 2023 /PRNewswire/ -- Aadi Bioscience, Inc. (NASDAQ: AADI), a commercial-stage biopharmaceutical company focused on developing and commercializing precision therapies for genetically-defined cancers with alterations in mTOR pathway...

Related Keywords

Marcy Graham ,Loretta Itri ,Aadi Bioscience ,Aadi Biosciences ,Nasdaq ,Society Of Gynecological Oncology ,Aadi Bioscience Inc ,Prnewswire Aadi Bioscience Inc ,Gynecological Oncology ,Annual Meeting ,Chief Medical Officer ,Poster Session ,Gynecological Oncology Annual Meeting ,Forward Looking Statements ,Private Securities Litigation Reform Act ,Quarterly Report ,